home All News open_in_new Full Article

China challenges US in AI drug race, but rivals still reliant on each other

China has emerged as a credible challenger to the US in artificial intelligence-driven drug discovery, where advantage depends not only on computing prowess but also on the ability to effectively mine data, from genomes to clinical trial results, according to Leung Chuen-yan, a private equity investor and life sciences scientist. “Globally, the way companies develop and use AI to discover drugs is similar, from finding the drug target and designing the molecule to planning clinical trials,” said...


today 9 h. ago attach_file Events

attach_file Science
attach_file Events
attach_file Events
attach_file Society
attach_file Politics
attach_file Politics
attach_file Technology
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Economics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Events
attach_file Economics


ID: 905030962
Add Watch Country

arrow_drop_down